These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 2817847

  • 21. Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass.
    Yokoyama Y, Matsumoto K, Ikawa K, Watanabe E, Yamamoto H, Imoto Y, Morikawa N, Takeda Y.
    Biol Pharm Bull; 2015; 38(11):1817-21. PubMed ID: 26521833
    [Abstract] [Full Text] [Related]

  • 22. Disposition of cefmetazole in healthy volunteers and patients with impaired renal function.
    Halstenson CE, Guay DR, Opsahl JA, Hirata CA, Olanoff LS, Novak E, Ko H, Cathcart KS, Matzke GR.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):519-23. PubMed ID: 2344159
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K, Ozawa Y.
    Antimicrob Agents Chemother; 1984 Nov; 26(5):647-51. PubMed ID: 6097172
    [Abstract] [Full Text] [Related]

  • 25. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD, Maxwell BM, Forland SC, Jacob L, Cutler RE.
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [Abstract] [Full Text] [Related]

  • 26. Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery.
    Martin C, Cotin A, Giraud A, Beccani-Argème M, Alliot P, Mallet MN, Argème M.
    Antimicrob Agents Chemother; 1998 May; 42(5):1093-7. PubMed ID: 9593133
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.
    Chimata M, Nagase M, Suzuki Y, Shimomura M, Kakuta S.
    Antimicrob Agents Chemother; 1993 Feb; 37(2):229-33. PubMed ID: 8452352
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure.
    Rohde B, Werner U, Hickstein H, Ehmcke H, Drewelow B.
    Eur J Clin Pharmacol; 1997 Feb; 53(2):111-5. PubMed ID: 9403281
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep.
    Escudero E, Espuny A, Vicente S, Cárceles CM.
    Can J Vet Res; 1999 Jan; 63(1):25-30. PubMed ID: 9918330
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves.
    Fernández-Varón E, Escudero-Pastor E, Cárceles-Rodríguez CM.
    Vet J; 2005 May; 169(3):437-43. PubMed ID: 15848786
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction.
    Wright N, Wise R.
    J Antimicrob Chemother; 1983 Jun; 11(6):583-7. PubMed ID: 6309731
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.